Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2016

High Content & Phenotypic Screening 2016



Keynote Speakers


Marc Bickle
Head of Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics


Neil Carragher
Principal Investigator, University of Edinburgh


Beverley Isherwood
Associate Director & Head High Content Biology, Innovative Medicines, AstraZeneca


Leo Price
CEO, Ocello B.V

Overview

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Agenda Topics

  • 3D Cell Models
  • High Content Screening
  • Image Analysis and Data Management
  • Phenotypic Drug Discovery

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44(0)1787 275645

Distinguished Faculty

Darren Cawkill, Associate Director, Pfizer
Sebastian Munck, Bio Imaging Core Leader, KU Leuven
Paul Andrews, Director/Consultant, Stem Cell Solutions Ltd
Matthias Nees, Group Leader, University of Turku
Thierry Dorval, Group Leader, Servier
Maria Montoya, Head, National Center for Cardiovascular Research
Sheraz Gul, Head of Assay Development & Screening, Fraunhofer-IME SP
Andreas Traube, Head of Department, Laboratory Automation and Biomanufacturing Engineering Fraunhofer IPA
Christian Parker, Lab Head, Novartis Institute For Biomedical Research
Xavier Gidrol, Laboratory Director, CEA Grenoble
Andreas Bender, Lecturer, The University of Cambridge
Alan Sandercock, Scientist II, MedImmune
Douglas Ross-Thriepland, Senior Scientist, Astrazeneca
Steven Titus, Staff Scientist, NIH - NCATS


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks